Compounds > 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide
Page last updated: 2024-11-05

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Bacteremia

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Bacteremia in 1 studies

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source

Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, K1
Robertson, DP1
Lappin, DF1
Ramage, G1

Other Studies

1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Bacteremia

ArticleYear
Commercial mouthwashes are ineffective against oral MRSA biofilms.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 115, Issue:5

    Topics: Aloe; Anti-Infective Agents, Local; Bacteremia; Bacteriological Techniques; Benzoates; Biofilms; Cet

2013